Patents-Review.com
ClassID:

21560 ⎘

A61K51/048 - CPC Classification

Classification description:

Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a NS, NS, NS, N chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3 DTPA (diethylenetriamine tetraacetic acid)

Recent Application in this class:
#1
20250295820
2025-09-25

Stable, concentrated radionuclide complex solutions

 #2
20250288703
2025-09-18

Alpha Emitter Compositions And Methods

 #3
20250213734
2025-07-03

Stable, concentrated radionuclide complex solutions

 #4
20250082791
2025-03-13

Stable, concentrated radionuclide complex solutions

 #5
20250082790
2025-03-13

Stable, concentrated radionuclide complex solutions

 #6
20250049969
2025-02-13

Stable, concentrated radionuclide complex solutions

 #7
20240285814
2024-08-29

Stable, concentrated radionuclide complex solutions

 #8
20240285813
2024-08-29

Stable, concentrated radionuclide complex solutions

 #9
20240285812
2024-08-29

Stable, concentrated radionuclide complex solutions

 #10
20240285811
2024-08-29

Stable, concentrated radionuclide complex solutions

 #11
20240285810
2024-08-29

DEVELOPMENT OF A NOVEL PET PROBE FOR TARGETED BACTERIAL IMAGING

 #12
20240252694
2024-08-01

CONJUGATES COMPRISING COVALENT BINDERS FOR TARGETING INTRACELLULAR KRAS G12C PROTEINS

 #13
20240245777
2024-07-25

COMPOSITION CONTAINING BUFFER

 #14
20240100204
2024-03-28

COMPOSITIONS AND METHODS FOR CANCER IMAGING AND RADIOTHERAPY

 #15
20240081941
2024-03-14

ULTRASOUND RESPONSIVE MICRO-COMPOSITE MARKERS

 #16
20240075171
2024-03-07

Stable, concentrated radionuclide complex solutions

 #17
20230348535
2023-11-02

RADIOMETAL-BINDING COMPOUNDS FOR DIAGNOSIS OR TREATMENT OF PROSTATE SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CANCER

 #18
20230129721
2023-04-27

STABILIZER FOR RADIOPHARMACEUTICALS AND RADIOPHARMACEUTICAL COMPOSITION COMPRISING THE SAME

 #19
20220233726
2022-07-28

NOVEL RADIOLABELLED COMPOUNDS FOR DIAGNOSIS OR TREATMENT OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CANCER

 #20
20220162241
2022-05-26

Chelated PSMA Inhibitors

 #21
20220142479
2022-05-12

Indicator fluids, systems, and methods for assessing movement of substances within, to or from a cerebrospinal fluid, brain or spinal cord compartment of a cranio-spinal cavity of a human

 #22
20220111080
2022-04-14

Compositions and methods of treating melanoma

 #23
20220072165
2022-03-10

RADIODRUG FOR DIAGNOSTIC/THERAPEUTIC USE IN NUCLEAR MEDICINE AND RADIO-GUIDED MEDICINE

 #24
20220040338
2022-02-10

Alpha emitter compositions and methods

 #25
20220031873
2022-02-03

Multi-Modal Contrast Agent For Medical Imaging

 #26
20210308287
2021-10-07

Method for extraction and purification of 68GA

 #27
20200353106
2020-11-12

Stable, concentrated radionuclide complex solutions

 #28
20200339625
2020-10-29

NOVEL RADIOMETAL-BINDING COMPOUNDS FOR DIAGNOSIS OR TREATMENT OF PROSTATE SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CANCER

 #29
20200170509
2020-06-04

Indicator fluids, systems, and methods for assessing movement of substances within, to or from a cerebrospinal fluid, brain or spinal cord compartment of a cranio-spinal cavity of a human

 #30
20200030464
2020-01-30

Stable, concentrated radionuclide complex solutions

 #31
20190351079
2019-11-21

Compositions and methods for cancer imaging and radiotherapy

 #32
20190336621
2019-11-07

Radioactive compound for diagnosis of malignant melanoma and use thereof

 #33
20190321495
2019-10-24

Compositions and methods of treating melanoma

 #34
20190309000
2019-10-10

Chelated PSMA inhibitors

 #35
20190211057
2019-07-11

Targeted prodrug cytosine deaminase fusion carrier and application thereof

 #36
20190192253
2019-06-27

Ultrasound responsive micro-composite markers

 #37
20190175736
2019-06-13

Composition containing buffer

 #38
20180263908
2018-09-20

Composition for preventing or treating ischemic diseases, containing liposomes in which VEGF-derived peptides are supported

 #39
20160206762
2016-07-21

Agents for the Molecular Imaging of Serine-Protease in Human Pathologies

 #40
20150098895
2015-04-09

SET AND METHOD FOR THE PRODUCTION OF A RADIOPHARMACEUTICAL

 #41
20140378677
2014-12-25

Version of FDG detectable by single-photon emission computed tomography

 #42
20140271465
2014-09-18

MATRIX METALLOPROTEASE (MMP) TARGETED AGENTS FOR IMAGING AND THERAPY

 #43
20140127139
2014-05-08

Compounds for diagnosing diseases associated with the expression of MUC5AC

 #44
20130302243
2013-11-14

RADIOLABELED NANOSYSTEM, PROCESS FOR THE PREPARATION THEREOF AND ITS USE

 #45
20120251446
2012-10-04

Peptide Conjugates Comprising Polyhistidine Sequence and Free Cysteine and Their Uses in Imaging

 #46
20120063993
2012-03-15

Therapeutic and diagnostic conjugates for use with multispecific antibodies

 #47
20110177004
2011-07-21

Metal chelate linked to a hexose carrier for use as a metallopharmaceutical diagnostic or therapeutic agent

 #48
20110176997
2011-07-21

Method to make porous materials and their applications

 #49
20090304582
2009-12-10

Imaging protocols

 #50
20090252675
2009-10-08

Radionuclide Therapy for Urinary Bladder Cancer

 #51
20090190807
2009-07-30

Reconstruction stabilizer and active vision

 #52
20050265922
2005-12-01

Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof

 #53
20050002945
2005-01-06

Therapeutic and diagnostic conjugates for use with multispecific antibodies